Published in Mol Pharmacol on December 01, 1999
The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci U S A (2002) 3.71
Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality. Proc Natl Acad Sci U S A (2003) 1.02
Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Res (2003) 0.97
Structure and hydration of the DNA-human topoisomerase I covalent complex. Biophys J (2001) 0.96
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study. Nucleic Acids Res (2005) 0.94
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin. J Biol Chem (2007) 0.94
Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics. Biophys J (2004) 0.94
Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex. PLoS One (2010) 0.94
A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance. Nucleic Acids Res (2008) 0.92
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations. Nucleic Acids Res (2008) 0.91
The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant. Nucleic Acids Res (2006) 0.88
Immunodetection of human topoisomerase I-DNA covalent complexes. Nucleic Acids Res (2016) 0.82
Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms. PLoS One (2016) 0.78
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin. J Biol Chem (2015) 0.77
Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes. Org Biomol Chem (2016) 0.76
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. J Exp Clin Cancer Res (2016) 0.75
Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors. Invest New Drugs (2015) 0.75
Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem (1999) 1.91
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol (2000) 1.85
Morphogenesis of bacteriophage phi 29 of Bacillus subtilis: oriented and quantized in vitro packaging of DNA protein gp3. J Virol (1983) 1.79
In vitro catenation and decatenation of DNA and a novel eucaryotic ATP-dependent topoisomerase. Cell (1980) 1.76
Intracellular location of the histonelike protein HU in Escherichia coli. J Bacteriol (1988) 1.75
Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res (1989) 1.73
Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Proc Natl Acad Sci U S A (1989) 1.45
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN. J Gastroenterol (1999) 1.44
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Template supercoiling by a chimera of yeast GAL4 protein and phage T7 RNA polymerase. Science (1990) 1.41
Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death. J Biol Chem (1997) 1.40
Prevalence and risk factors for nosocomial infections in hospitals of the Veneto region, north-eastern Italy. Infection (2008) 1.37
In vitro assembly of the Bacillus subtilis bacteriophage phi 29. Proc Natl Acad Sci U S A (1981) 1.31
Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol (1992) 1.29
Morphogenesis of bacteriophage phi 29 of Bacillus subtilis: DNA-gp3 intermediate in in vivo and in vitro assembly. J Virol (1982) 1.26
SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I. Proc Natl Acad Sci U S A (1995) 1.21
Comparative mutational analysis of wild-type and stretched tRNA3(Leu) gene promoters. Proc Natl Acad Sci U S A (1987) 1.21
Use of on-section immunolabeling and cryosubstitution for studies of bacterial DNA distribution. J Bacteriol (1987) 1.20
Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem (1996) 1.17
Variant cDNAs encoding proteins similar to the alpha subunit of chicken CapZ. Cell Motil Cytoskeleton (1991) 1.16
A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest. Genetics (1993) 1.14
Separation of RNA transcription and processing activities from X. laevis germinal vesicles. Cell (1979) 1.14
Heart involvement in AIDS: a prospective study during various stages of the disease. Eur Heart J (1992) 1.12
Bacteriophage phi 29 proteins required for in vitro DNA-gp3 packaging. J Virol (1984) 1.12
Observation of high-energy neutrinos using Cerenkov detectors embedded deep in Antarctic ice. Nature (2001) 1.12
Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res (1995) 1.11
CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage. Proc Natl Acad Sci U S A (1999) 1.10
Limits on neutrino emission from gamma-ray bursts with the 40 string IceCube detector. Phys Rev Lett (2011) 1.08
Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J Biol Chem (1993) 1.07
Molecular dissection of a protein SopB essential for Escherichia coli F plasmid partition. J Biol Chem (1996) 1.07
Critical comparison of nine different self-administered questionnaires for the evaluation of disability caused by low back pain. Eura Medicophys (2005) 1.05
A high yield purification of the human transferrin receptor and properties of its major extracellular fragment. J Biol Chem (1988) 1.05
Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum. Immunity (2001) 1.04
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med (2001) 1.02
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate. J Biol Chem (2000) 1.00
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens (2003) 0.99
Morphogenesis of bacteriophage phi 29 of Bacillus subtilis: prohead restoration for DNA-gp3 packaging and assembly. J Virol (1985) 0.98
[Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis]. Reumatismo (2005) 0.97
Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology (1993) 0.97
A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. J Biol Chem (1995) 0.96
Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. Biochim Biophys Acta (1998) 0.96
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother (2001) 0.95
Nontraumatic mediastinitis. JAMA (1976) 0.95
Outcome after discontinuation of antiepileptic drug therapy in children with epilepsy. Epilepsia (1989) 0.95
Cascades of mammalian caspase activation in the yeast Saccharomyces cerevisiae. J Biol Chem (1999) 0.94
Abdominal hypertension in Meigs' syndrome. Eur J Surg Oncol (2007) 0.93
HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol (1994) 0.93
Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours. Int J Androl (2011) 0.91
Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine. J Biol Chem (1998) 0.91
Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA. J Biol Chem (1998) 0.90
Topoisomerase II forms multimers in vitro: effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain. Mol Cell Biol (1994) 0.90
Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. J Biol Chem (1998) 0.89
Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast. J Biol Chem (1997) 0.89
The peptide binding specificity of HLA-B27 subtypes. Immunogenetics (1994) 0.89
Outbreak of African tick-bite fever in six Italian tourists returning from South Africa. Eur J Clin Microbiol Infect Dis (2002) 0.88
Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae. Ann N Y Acad Sci (2000) 0.88
Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Juvenile Headache Collaborative Study Group. Headache (1995) 0.87
A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people. Acta Psychiatr Scand (1990) 0.87
[Histologic evaluation of bone regeneration in cases of limb lengthening by Ilizarov's technique. An experimental study in the dog]. Ann Chir (1997) 0.86
H. pylori infection in HIV-positive patients. A serohistological study. Dig Dis Sci (1997) 0.85
MR appearance of the extensor digitorum manus brevis muscle: a pseudotumor of the hand. AJR Am J Roentgenol (1995) 0.84
Epidemic Kaposi's sarcoma in female AIDS patients--a report of 23 Italian cases. AIDS (1991) 0.84
A multistep process for the dispersal of a Y chromosomal lineage in the Mediterranean area. Ann Hum Genet (2001) 0.84
Bone morphogenetic proteins in orthopedics: from basic science to clinical practice. Orthopedics (1999) 0.83
Differential expression of heat shock protein (HSP70) mRNAs in rat cells. Exp Cell Res (1996) 0.83
Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. Cancer Chemother Pharmacol (1994) 0.82
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Res Treat (2014) 0.82
Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins. Cancer Res (1995) 0.82
Mode of action of the schistosomicide hycanthone: site of DNA alkylation. Mol Biochem Parasitol (1990) 0.82
Nerve growth factor may stimulate either division or differentiation of cloned C1300 neuroblastoma cells in serum-free cultures. J Cell Physiol (1980) 0.82
Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study. Aliment Pharmacol Ther (1999) 0.82
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology (1994) 0.81
5-Methylcytosine in genes with methylation-dependent regulation. FEBS Lett (1993) 0.80
Fiber-optic fourier transform mid-infrared reflectance spectroscopy: a suitable technique for in situ studies of mural paintings. Appl Spectrosc (2007) 0.80
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. J Proteome Res (2014) 0.80
Leptospirosis following a flood in the Veneto area, North-east Italy. Ann Ig (2006) 0.80
High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners. Infection (1999) 0.80
The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum Immunol (1994) 0.80
32-year old patient presenting with autoimmune polyglandular syndrome. Eur J Med Res (2001) 0.79
Six cases of travel-associated Legionnaires' disease in Ischia involving four countries. Infection (1992) 0.79
Effect of citicoline on visual acuity in amblyopia: preliminary results. Graefes Arch Clin Exp Ophthalmol (1995) 0.79
Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery. Cancer Res (1993) 0.79
Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae. Methods Mol Biol (2001) 0.79
Study of yeast DNA topoisomerase II and its truncation derivatives by transmission electron microscopy. J Biol Chem (1997) 0.79
Constitutive production of Interleukin-1 by the human continuous cell line, CM-S. Cell Immunol (1983) 0.78
Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects. Curr Eye Res (1998) 0.78
Limits on a muon flux from neutralino annihilations in the sun with the IceCube 22-string detector. Phys Rev Lett (2009) 0.78
Improving blood glucose monitoring in a hospital setting using the PDCA approach. Plan, do, check, act cycle. J Nurs Care Qual (1993) 0.78
The development of auditory and visual evoked potentials in early treated phenylketonuric children. Electroencephalogr Clin Neurophysiol (1991) 0.78
Interleukin-1 production by a cloned line of human monocyte-like cells (CM-SM). Correlation with state of differentiation. Scand J Immunol (1985) 0.78
A pediatric emergency department follow-up system: completing the cycle of care. Pediatr Emerg Care (2001) 0.78
Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays. Methods Mol Biol (2001) 0.77
Neuropsychological correlates of subclinical paroxysmal EEG activity in children with epilepsy. 1: Qualitative features (generalized and focal abnormalities). Funct Neurol (1989) 0.77
Neuropsychological correlates of subclinical paroxysmal EEG activity in children with epilepsy. 2: Quantitative aspects. Funct Neurol (1989) 0.77
Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug. J Biomol Struct Dyn (2008) 0.76
HGV/GBV-C infection in patients with acute hepatitis of different etiology and in patients with chronic hepatitis C. J Gastroenterol (1998) 0.76
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor. Br J Cancer (1991) 0.76